Wendy Henderson profile picture

Wendy Henderson

Wendy is a proven blogger and social media manager who has helped to build online communities for businesses and organizations. She currently heads the website’s social outreach online through social media platforms such as Facebook, Twitter, and Pinterest.

At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.

Articles by Wendy Henderson

https://www.youtube.com/watch?v=n2YQ3H4XT3c If you’re active on the Internet, particularly in groups and forums regarding chronic illness, you’ve definitely noticed the…

Esbriet (pirfenidone) is an anti-fibrotic and anti-inflammatory drug used in the treatment of mild to moderate idiopathic pulmonary fibrosis (IPF). Manufactured by Genentech and given FDA approval in 2014, the drug reduces the amount of lung fibrosis by blocking secretions responsible for excessive collagen production. It also reduces inflammation in the lungs.